Literature DB >> 34788807

Mutations of the histone linker H1-4 in neurodevelopmental disorders and functional characterization of neurons expressing C-terminus frameshift mutant H1.4.

Martine W Tremblay1,2, Matthew V Green2, Benjamin M Goldstein2, Andrew I Aldridge1,2, Jill A Rosenfeld3,4, Haley Streff3, Wendy D Tan2, William Craigen3, Nasim Bekheirnia5, Saeed Al Tala6, Anne E West1,2, Yong-Hui Jiang7,8,9.   

Abstract

Rahman syndrome (RMNS) is a rare genetic disorder characterized by mild to severe intellectual disability, hypotonia, anxiety, autism spectrum disorder, vision problems, bone abnormalities and dysmorphic facies. RMNS is caused by de novo heterozygous mutations in the histone linker gene H1-4; however, mechanisms underlying impaired neurodevelopment in RMNS are not understood. All reported mutations associated with RMNS in H1-4 are small insertions or deletions that create a shared frameshift, resulting in a H1.4 protein that is both truncated and possessing an abnormal C-terminus frameshifted tail (H1.4 CFT). To expand understanding of mutations and phenotypes associated with mutant H1-4, we identified new variants at both the C- and N-terminus of H1.4. The clinical features of mutations identified at the C-terminus are consistent with other reports and strengthen the support of pathogenicity of H1.4 CFT. To understand how H1.4 CFT may disrupt brain function, we exogenously expressed wild-type or H1.4 CFT protein in rat hippocampal neurons and assessed neuronal structure and function. Genome-wide transcriptome analysis revealed ~ 400 genes altered in the presence of H1.4 CFT. Neuronal genes downregulated by H1.4 CFT were enriched for functional categories involved in synaptic communication and neuropeptide signaling. Neurons expressing H1.4 CFT also showed reduced neuronal activity on multielectrode arrays. These data are the first to characterize the transcriptional and functional consequence of H1.4 CFT in neurons. Our data provide insight into causes of neurodevelopmental impairments associated with frameshift mutations in the C-terminus of H1.4 and highlight the need for future studies on the function of histone H1.4 in neurons.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34788807      PMCID: PMC9271223          DOI: 10.1093/hmg/ddab321

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   5.121


  37 in total

1.  Distribution of somatic H1 subtypes is non-random on active vs. inactive chromatin II: distribution in human adult fibroblasts.

Authors:  M H Parseghian; R L Newcomb; B A Hamkalo
Journal:  J Cell Biochem       Date:  2001       Impact factor: 4.429

2.  MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites.

Authors:  Rajarshi P Ghosh; Rachel A Horowitz-Scherer; Tatiana Nikitina; Luda S Shlyakhtenko; Christopher L Woodcock
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

3.  Fiji: an open-source platform for biological-image analysis.

Authors:  Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona
Journal:  Nat Methods       Date:  2012-06-28       Impact factor: 28.547

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  H1 linker histone promotes epigenetic silencing by regulating both DNA methylation and histone H3 methylation.

Authors:  Seung-Min Yang; Byung Ju Kim; Laura Norwood Toro; Arthur I Skoultchi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-09       Impact factor: 11.205

6.  Genome-wide distribution of linker histone H1.0 is independent of MeCP2.

Authors:  Aya Ito-Ishida; Hari Krishna Yamalanchili; Yingyao Shao; Steven A Baker; Laura D Heckman; Laura A Lavery; Ji-Yoen Kim; Laura M Lombardi; Yaling Sun; Zhandong Liu; Huda Y Zoghbi
Journal:  Nat Neurosci       Date:  2018-05-25       Impact factor: 24.884

7.  Frameshift mutations at the C-terminus of HIST1H1E result in a specific DNA hypomethylation signature.

Authors:  Andrea Ciolfi; Erfan Aref-Eshghi; Simone Pizzi; Lucia Pedace; Evelina Miele; Jennifer Kerkhof; Elisabetta Flex; Simone Martinelli; Francesca Clementina Radio; Claudia A L Ruivenkamp; Gijs W E Santen; Emilia Bijlsma; Daniela Barge-Schaapveld; Katrin Ounap; Victoria Mok Siu; R Frank Kooy; Bruno Dallapiccola; Bekim Sadikovic; Marco Tartaglia
Journal:  Clin Epigenetics       Date:  2020-01-07       Impact factor: 6.551

8.  The NMDA receptor subunit GluN3A regulates synaptic activity-induced and myocyte enhancer factor 2C (MEF2C)-dependent transcription.

Authors:  Liang-Fu Chen; Michelle R Lyons; Fang Liu; Matthew V Green; Nathan G Hedrick; Ashley B Williams; Arthy Narayanan; Ryohei Yasuda; Anne E West
Journal:  J Biol Chem       Date:  2020-05-11       Impact factor: 5.486

Review 9.  H1 histones: current perspectives and challenges.

Authors:  Sean W Harshman; Nicolas L Young; Mark R Parthun; Michael A Freitas
Journal:  Nucleic Acids Res       Date:  2013-08-14       Impact factor: 16.971

10.  Maternally inherited genetic variants of CADPS2 are present in autism spectrum disorders and intellectual disability patients.

Authors:  Elena Bonora; Claudio Graziano; Fiorella Minopoli; Elena Bacchelli; Pamela Magini; Chiara Diquigiovanni; Silvia Lomartire; Francesca Bianco; Manuela Vargiolu; Piero Parchi; Elena Marasco; Vilma Mantovani; Luca Rampoldi; Matteo Trudu; Antonia Parmeggiani; Agatino Battaglia; Luigi Mazzone; Giada Tortora; Elena Maestrini; Marco Seri; Giovanni Romeo
Journal:  EMBO Mol Med       Date:  2014-04-06       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.